Compare CASH & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CASH | PAHC |
|---|---|---|
| Founded | 1954 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 1996 | 2014 |
| Metric | CASH | PAHC |
|---|---|---|
| Price | $96.56 | $53.75 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 4 |
| Target Price | ★ $96.33 | $41.25 |
| AVG Volume (30 Days) | 186.4K | ★ 281.9K |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | 0.21% | ★ 0.87% |
| EPS Growth | 18.88 | ★ 1883.33 |
| EPS | ★ 1.57 | 1.32 |
| Revenue | ★ $839,894,000.00 | $833,350,000.00 |
| Revenue This Year | $7.56 | $17.03 |
| Revenue Next Year | $6.02 | $3.82 |
| P/E Ratio | $61.50 | ★ $41.67 |
| Revenue Growth | ★ 11.29 | 4.12 |
| 52 Week Low | $65.93 | $16.16 |
| 52 Week High | $97.14 | $60.08 |
| Indicator | CASH | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 69.15 | 47.67 |
| Support Level | $87.19 | $50.72 |
| Resistance Level | N/A | $56.64 |
| Average True Range (ATR) | 1.74 | 2.65 |
| MACD | 0.62 | -0.29 |
| Stochastic Oscillator | 95.64 | 26.10 |
Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.